1. Home
  2. CGEM vs DRD Comparison

CGEM vs DRD Comparison

Compare CGEM & DRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • DRD
  • Stock Information
  • Founded
  • CGEM 2016
  • DRD 1895
  • Country
  • CGEM United States
  • DRD South Africa
  • Employees
  • CGEM N/A
  • DRD N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • DRD Precious Metals
  • Sector
  • CGEM Health Care
  • DRD Basic Materials
  • Exchange
  • CGEM Nasdaq
  • DRD Nasdaq
  • Market Cap
  • CGEM 482.7M
  • DRD 1.6B
  • IPO Year
  • CGEM 2021
  • DRD N/A
  • Fundamental
  • Price
  • CGEM $5.93
  • DRD $23.96
  • Analyst Decision
  • CGEM Strong Buy
  • DRD Strong Buy
  • Analyst Count
  • CGEM 8
  • DRD 1
  • Target Price
  • CGEM $27.25
  • DRD $18.75
  • AVG Volume (30 Days)
  • CGEM 544.0K
  • DRD 857.2K
  • Earning Date
  • CGEM 11-06-2025
  • DRD 01-01-0001
  • Dividend Yield
  • CGEM N/A
  • DRD 1.92%
  • EPS Growth
  • CGEM N/A
  • DRD 68.66
  • EPS
  • CGEM N/A
  • DRD 1.46
  • Revenue
  • CGEM N/A
  • DRD $443,674,785.00
  • Revenue This Year
  • CGEM N/A
  • DRD $6.65
  • Revenue Next Year
  • CGEM N/A
  • DRD $20.77
  • P/E Ratio
  • CGEM N/A
  • DRD $16.03
  • Revenue Growth
  • CGEM N/A
  • DRD 26.26
  • 52 Week Low
  • CGEM $5.90
  • DRD $8.38
  • 52 Week High
  • CGEM $18.62
  • DRD $24.49
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 29.91
  • DRD 82.15
  • Support Level
  • CGEM $6.44
  • DRD $21.84
  • Resistance Level
  • CGEM $6.76
  • DRD $23.00
  • Average True Range (ATR)
  • CGEM 0.42
  • DRD 0.83
  • MACD
  • CGEM -0.12
  • DRD 0.24
  • Stochastic Oscillator
  • CGEM 1.58
  • DRD 92.58

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About DRD DRDGOLD Limited

DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields; and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.

Share on Social Networks: